$80 Million Fund Boosts Research into Exceptional Longevity

In a groundbreaking development in the field of gerontology and genetic research, Washington University School of Medicine in St. Louis has secured an $80 million grant to propel forward its pioneering investigation into the enigmatic phenomenon of exceptional human longevity. This substantial funding renewal enables the continuation of the Long Life Family Study, an expansive international initiative that meticulously examines multiple generations of families exhibiting an extraordinary prevalence of individuals who surpass typical life expectancy thresholds, some even reaching centenarian and supercentenarian milestones.

Originating in 2004, the Long Life Family Study draws upon WashU Medicine’s esteemed heritage of leadership in genetics and genomics, a legacy marked by significant contributions to the Human Genome Project and groundbreaking advances in DNA sequencing technology. By generating and interrogating whole-genome sequence data from thousands of participants, researchers seek to isolate genetic variants potentially responsible for extended healthspan and resistance to age-related morbidities. The data accrued over the past two decades has underscored remarkable cardiovascular resilience among long-lived family cohorts, manifesting in superior blood pressure profiles and a reduced incidence of type 2 diabetes relative to the general population.

The imperative of this research is underscored by global demographic trends: populations are aging at an unprecedented rate, precipitating a surge in chronic conditions such as cardiovascular diseases, metabolic syndromes, and neurodegenerative disorders including Alzheimer’s disease. Epidemiological models predict that by 2050, the prevalence of individuals over fifty living with one or more chronic ailments may double, imposing profound public health challenges.

Principal Investigator Michael A. Province, PhD, whose expertise in statistical genetics guides the study, articulates the research’s dual focus on pathogenic and salutogenic genetics. While the majority of medical genetics research has traditionally sought deleterious mutations underpinning disease, this study hones in on protective genetic variants that may confer enhanced physiological robustness and disease resistance, thereby enabling healthy longevity. The identification of these advantageous alleles holds promising translational potential for interventions designed to mimic or amplify their effects in the broader population.

The study’s cohort encompasses over 5,000 individuals from more than 530 families across the United States and Denmark. The oldest participants were initially around ninety years of age at enrollment in 2006, with several surpassing 110 years, offering a unique intergenerational perspective. Children and grandchildren from these initial families, now entering their sixties to eighties, furnish a rich dataset for dissecting heritable genetic factors. Researchers utilize the extensively documented Framingham Heart Study populations as comparative controls to benchmark physiological and genetic differences.

Recent analyses have elucidated heterogeneity in the phenotypic expressions of health among these families, indicating multiple pathways toward decelerated biological aging. Some pedigrees exhibit exceptional cognitive preservation, others maintain superior pulmonary function or muscular strength, highlighting diverse biological mechanisms of resilience. Notably, none of these protective advantages were uniform, suggesting complex gene-environment interactions underscore longevity.

One salient finding is the disproportionately low prevalence of diabetes within long-lived families, despite comparable obesity rates to control populations—a paradox suggesting the presence of protective genetic or metabolic pathways mitigating typical obesity-associated risks. Researchers pinpointed a genetic variant correlated with reduced hemoglobin A1c levels, implicating it as a candidate locus for diabetes resistance. These insights challenge prevailing paradigms and open new avenues for understanding metabolic health in advanced age.

Further advancing the science of aging, the team has identified a novel gene linked with late-onset Alzheimer’s disease in these populations, providing fresh targets for therapeutic intervention. Intriguingly, a distinct genetic variant simultaneously correlates with enhanced longevity and lower blood pressure but paradoxically associates with a marginally increased risk of certain cancers, such as those of the head and neck. This exemplifies the complex pleiotropic effects of genetic variation, cautioning against oversimplified approaches to gene-targeted therapies.

Responding to technological progress, the study will reanalyze the entire genomic dataset using next-generation “long-read” sequencing methodologies. Unlike prior short-read sequencing, long-read technology can resolve complex genomic regions, including structural variants and repetitive sequences often labeled as “dark matter” of the genome. The integration of these cutting-edge tools is expected to unveil previously obscured genetic factors contributing to longevity and healthy aging.

As the original oldest-generation participants have largely passed away, the research team plans to enroll new families exemplifying exceptional longevity, with a pronounced emphasis on increasing ethnic and genetic diversity to include families of African descent. Expanding the cohort diversity enhances the power to disentangle causal protective variants from linked neutral variants, which is crucial for accurately identifying targets for clinical translation.

This large-scale, international collaborative endeavor involves notable research institutions spanning the United States and Denmark, including Boston University, Columbia University, University of Pittsburgh, and others, reflecting the global significance of this quest to decode the genetic foundation of human lifespan variation. The study is funded by the National Institute on Aging under the National Institutes of Health, emphasizing its pivotal role in national biomedical research initiatives.

Washington University School of Medicine remains at the forefront of this high-impact genetic aging research, reinforcing its position as a global leader in biomedical innovation with a rich history of genome science. Their commitment to integrating cutting-edge genomics with longitudinal phenotyping in uniquely selected populations continues to generate transformative insights, illuminating paths towards extending healthy human life.

News Publication Date: Not specified

Web References:
– https://medicine.washu.edu/news/families-with-long-healthy-life-spans-focus-of-68-million-grant/
– https://genetics.wustl.edu/people/michael-province-phdprofessor-and-director-division-of-statistical-genetics-dsg/
– https://medicine.washu.edu/